To address the request for FAQs on Arabidopsis thaliana At4g29670 antibody usage in academic research, we synthesize methodological insights from antibody engineering, validation, and application studies. Below are structured questions reflecting both foundational and advanced research considerations.
Methodology:
Perform Western blotting using Arabidopsis knockout mutants for At4g29670 as negative controls. Include wild-type lysates for comparison.
Use immunofluorescence with tissue-specific mutants to confirm localization patterns.
Validate cross-reactivity by testing against homologous proteins (e.g., At4g25290 or At4g17410) using competitive ELISA .
Guidelines:
| Concentration (µg/mL) | Target Enrichment (%) | Non-Specific Binding (%) |
|---|---|---|
| 0.1 | 12 | 45 |
| 0.5 | 58 | 22 |
| 2.5 | 85 | 8 |
| 5.0 | 87 | 15 |
Data adapted from oligo-conjugated antibody titration studies .
Analysis Framework:
Use biolayer interferometry to quantify binding kinetics (KD, Kon/Koff) of antibodies produced in different B-cell lineages .
Compare paratope sequences from hybridomas to identify allelic variants affecting epitope recognition.
Resolve discrepancies via structural modeling (e.g., PyMOL) of antibody-antigen interfaces .
Solutions:
Employ cross-blocking with non-target proteins (e.g., Fc receptors) during staining.
Use single-cell RNA-seq paired with CITE-seq to correlate protein expression with transcriptional data, filtering false positives .
Optimize buffer additives (e.g., 0.1% Tween-20, 5% BSA) to reduce hydrophobic interactions .
Workflow:
Scenario: Discrepancies in subcellular localization between studies.